hMan2c1 transgene promotes tumor progress in mice

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Alpha-mannosidase is a key enzyme in glycoprotein metabolism.
• The specific biological role of alpha-mannosidase Man2c1 (hMan2c1) requires further investigation.
• Transgenic mouse models are crucial for studying gene function in vivo.

Purpose of the Study:

• To generate and characterize human alpha-mannosidase (hMan2c1) transgenic mice.
• To investigate the biological significance of hMan2c1 in vivo.
• To explore the impact of hMan2c1 on tumor progression and host immunity.

Main Methods:

• Generation of hMan2c1 transgenic mice through genomic PCR.
• Confirmation of hMan2c1 mRNA expression using RT-PCR.
• Enzymatic activity assays and Concanavalin A (Con A) binding analysis.
• Implantation of hepatoma H22 and sarcoma S180 cells to assess tumor growth and metastasis.
• Evaluation of humoral and cellular immunity, including antibody response and NK cell cytotoxicity.

Main Results:

• hMan2c1 transgene was successfully integrated and expressed in multiple transgenic mouse lines.
• Enhanced alpha-mannosidase enzymatic activity and altered N-glycosylation patterns were observed in transgenic mice.
• hMan2c1 significantly promoted the growth, invasion, and lung metastasis of implanted H22 and S180 tumors.
• Transgenic mice exhibited a reduced antibody response to BSA, suggesting potential suppression of anti-tumor immunity.
• Natural killer (NK) cell cytotoxicity remained unaffected by the hMan2c1 transgene.

Conclusions:

• The hMan2c1 transgene plays a significant role in promoting tumor progression.
• Altered N-glycosylation and potential immune modulation by hMan2c1 contribute to enhanced tumor growth and metastasis.
• hMan2c1 represents a potential therapeutic target for cancer treatment.